MetaCap

Compugen (CGEN) News

NASDAQ: CGENHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.84-0.04 (-2.13%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CGEN news summary

We found 3 recent headlines mentioning Compugen (CGEN): 0 in the past week and 3 in the past 30 days, most often from Nasdaq. For price context, CGEN is down 2.13% at $1.84. The most recent story, "Compugen (CGEN) Q3 2026 Earnings Call Transcript", was published by Nasdaq on Nov 9, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Compugen headlines

Stocks mentioned alongside CGEN

Compare CGEN